Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Plasma lipid metabolites are associated with gestational age but not bronchopulmonary dysplasia.

Rogers LK, Young CM, Pennell ML, Tipple TE, Leonhart KL, Welty SE.

Acta Paediatr. 2012 Aug;101(8):e321-6. doi: 10.1111/j.1651-2227.2012.02694.x. Epub 2012 May 2.

2.

Developmental changes in polyunsaturated fetal plasma phospholipids and feto-maternal plasma phospholipid ratios and their association with bronchopulmonary dysplasia.

Bernhard W, Raith M, Koch V, Maas C, Abele H, Poets CF, Franz AR.

Eur J Nutr. 2016 Oct;55(7):2265-74. doi: 10.1007/s00394-015-1036-5. Epub 2015 Sep 12.

PMID:
26363610
3.

Role of antioxidant nutrients and lipid peroxidation in premature infants with respiratory distress syndrome and bronchopulmonary dysplasia.

Falciglia HS, Johnson JR, Sullivan J, Hall CF, Miller JD, Riechmann GC, Falciglia GA.

Am J Perinatol. 2003 Feb;20(2):97-107.

PMID:
12660915
4.

Urinary leukotriene E(4) excretion during the first month of life and subsequent bronchopulmonary dysplasia in premature infants.

Sheikh S, Null D, Gentile D, Bimle C, Skoner D, McCoy K, Guthrie R.

Chest. 2001 Jun;119(6):1749-54.

PMID:
11399701
5.

Plasma 3-nitrotyrosine is elevated in premature infants who develop bronchopulmonary dysplasia.

Banks BA, Ischiropoulos H, McClelland M, Ballard PL, Ballard RA.

Pediatrics. 1998 May;101(5):870-4.

PMID:
9565417
6.

Early clinical markers for the development of bronchopulmonary dysplasia: soluble E-Selectin and ICAM-1.

Ramsay PL, O'Brian Smith E, Hegemier S, Welty SE.

Pediatrics. 1998 Oct;102(4 Pt 1):927-32.

PMID:
9755267
7.

Angiopoietin-1 and endostatin levels in cord plasma predict the development of bronchopulmonary dysplasia in preterm infants.

Mohamed WA, Niyazy WH, Mahfouz AA.

J Trop Pediatr. 2011 Oct;57(5):385-8. doi: 10.1093/tropej/fmq112. Epub 2010 Dec 2.

PMID:
21131270
8.

N-terminal pro-B-type natriuretic peptide as a marker of bronchopulmonary dysplasia in premature infants.

Joseph L, Nir A, Hammerman C, Goldberg S, Ben Shalom E, Picard E.

Am J Perinatol. 2010 May;27(5):381-6. doi: 10.1055/s-0029-1243312. Epub 2009 Dec 11.

PMID:
20013606
9.

Vascular Endothelial Growth Factor/Placental Growth Factor Heterodimer Levels in Preterm Infants with Bronchopulmonary Dysplasia.

Procianoy RS, Hentges CR, Silveira RC.

Am J Perinatol. 2016 Apr;33(5):480-5. doi: 10.1055/s-0035-1566294. Epub 2015 Nov 3.

PMID:
26529476
10.

Hospital variation and risk factors for bronchopulmonary dysplasia in a population-based cohort.

Lapcharoensap W, Gage SC, Kan P, Profit J, Shaw GM, Gould JB, Stevenson DK, O'Brodovich H, Lee HC.

JAMA Pediatr. 2015 Feb;169(2):e143676. doi: 10.1001/jamapediatrics.2014.3676. Epub 2015 Feb 2.

PMID:
25642906
11.

Soluble E-selectin, soluble L-selectin and soluble ICAM-1 in bronchopulmonary dysplasia, and changes with dexamethasone.

Ballabh P, Kumari J, Krauss AN, Shin JJ, Jain A, Auld PA, Lesser ML, Cunningham-Rundles S.

Pediatrics. 2003 Mar;111(3):461-8.

PMID:
12612222
12.

Cord blood KL-6, a specific lung injury marker, correlates with the subsequent development and severity of atypical bronchopulmonary dysplasia.

Kim DH, Kim HS, Shim SY, Lee JA, Choi CW, Kim EK, Kim BI, Choi JH.

Neonatology. 2008;93(4):223-9. Epub 2007 Nov 16.

PMID:
18025794
13.

Below median birth weight in appropriate-for-gestational-age preterm infants as a risk factor for bronchopulmonary dysplasia.

Kewitz G, Wudel S, Hopp H, Hopfenmüller W, Vogel M, Roots I.

J Perinat Med. 2008;36(4):359-64. doi: 10.1515/JPM.2008.056.

PMID:
18598128
14.

[Selenium status and bronchopulmonary dysplasia in premature infants <1,500 g].

Merz U, Peschgens T, Dott W, Hörnchen H.

Z Geburtshilfe Neonatol. 1998 Sep;202(5):203-6. German.

PMID:
9857446
15.

MicroRNA expression aberration associated with bronchopulmonary dysplasia in preterm infants: a preliminary study.

Wu YT, Chen WJ, Hsieh WS, Tsao PN, Yu SL, Lai CY, Lee WC, Jeng SF.

Respir Care. 2013 Sep;58(9):1527-35. doi: 10.4187/respcare.02166. Epub 2013 Mar 12.

16.

[Respiratory morbidity after hospital discharge in premature infants born at < or = 32 weeks gestation with bronchopulmonary dysplasia].

Pérez Pérez G, Navarro Merino M, Romero Pérez MM, Sáenz Reguera C, Pons Tubío A, Polo Padillo J.

An Pediatr (Barc). 2004 Feb;60(2):117-24. Spanish.

17.

Use of the intramuscular relative-dose-response test to predict bronchopulmonary dysplasia in premature infants.

Zachman RD, Samuels DP, Brand JM, Winston JF, Pi JT.

Am J Clin Nutr. 1996 Jan;63(1):123-9.

PMID:
8604659
18.

Angiogenic Factors in Cord Blood of Preterm Infants Predicts Subsequently Developing Bronchopulmonary Dysplasia.

Yang WC, Chen CY, Chou HC, Hsieh WS, Tsao PN.

Pediatr Neonatol. 2015 Dec;56(6):382-5. doi: 10.1016/j.pedneo.2015.02.001. Epub 2015 Apr 20.

19.

Ureaplasma urealyticum colonization, prematurity and bronchopulmonary dysplasia.

van Waarde WM, Brus F, Okken A, Kimpen JL.

Eur Respir J. 1997 Apr;10(4):886-90. Review.

20.

Impaired growth at birth and bronchopulmonary dysplasia classification: beyond small for gestational age.

Nyp MF, Taylor JB, Norberg M, Truog WE.

Am J Perinatol. 2015 Jan;32(1):75-82. doi: 10.1055/s-0034-1376181. Epub 2014 May 16.

PMID:
24839148

Supplemental Content

Support Center